Please wait...
About This Project
We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Browse Other Projects on Experiment
Related Projects
Metabolizing Microplastics for Human Health
Plastics have revolutionized material science engineering. However, the use of plastic has had unintended...
How do chemical exposures trigger autoimmune diseases?
The cause of onset of autoimmune disease is poorly understood, but may be linked to exposure to certain...
Dermatology AI Assistant to Empower Primary Care Providers in Zaatari Refugee Camp in Jordan
An AI-assisted dermatology tool for refugees, utilizing imaging and symptom questionnaires to improve diagnostic...